Montserrat Tech Update: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Montserrat Tech Update.

Press releases published on August 24, 2026

Aug. 24, 2026

Merlin Designated a New Zealand Part 146 Aircraft Design Organization, Advancing Its Path to Commercial Operations

Indeterminate GlobeNewswire

Aug. 24, 2026

Datacentrex Secures Colocation Capacity and Set to Expand Mining Fleet by More Than 500 Additional ElphaPex DG2 Miners

Indeterminate GlobeNewswire

Aug. 24, 2026

Rhythm Pharmaceuticals Announces MHLW Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity (HO) in Japan

Indeterminate GlobeNewswire

Aug. 24, 2026

Mindway Launches Personalized Mental Wellness App to Help Users Stop Overthinking

Indeterminate GlobeNewswire

Aug. 24, 2026

Intertextile Shanghai Home Textiles Autumn 2026 Successfully Concludes, 41Caijing’s Practical Methodology Draws Attention

Indeterminate GlobeNewswire

Aug. 24, 2026

BridgeBio to Present New Acoramidis Data from Open-Label Extension Analyses in ATTR-CM at ESC Congress 2026

Indeterminate GlobeNewswire

Aug. 24, 2026

Cineplex Announces Renewal of Normal Course Issuer Bid

Indeterminate GlobeNewswire

Aug. 24, 2026

Crane NXT Announces Appointment of Jason Lund as President of Crane Payment Innovations and Group President of the Detection and Traceability Technologies Segment

Indeterminate GlobeNewswire

Aug. 24, 2026

Arbutus Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share

Indeterminate GlobeNewswire

Aug. 24, 2026

Kraig Biocraft Laboratories Boosts Spider Silk Output More Than 30% During the Most Technically Challenging Season of the Year

Indeterminate GlobeNewswire

Aug. 24, 2026

VERAXA Biotech and Secarna Pharmaceuticals Achieve Research Milestone in Antibody Oligonucleotide Conjugate (AOC) Alliance

Indeterminate GlobeNewswire

Aug. 24, 2026

Monte Rosa Therapeutics Announces First Patient Dosed in MODeFIRe-1, a Phase 2 Study of MRT-2359 in Combination with Apalutamide in Patients with AR Mutation-Positive Metastatic Castration-Resistant Prostate Cancer

Indeterminate GlobeNewswire

Aug. 24, 2026

Rapport Therapeutics to Host Virtual KOL Event on the Unmet Need in Bipolar Mania and the RAP-219 Clinical Program

Indeterminate GlobeNewswire

Aug. 24, 2026

Descartes Acquires Tai

Indeterminate GlobeNewswire

Aug. 24, 2026

Ciphertex® Launches AI•S to Address Enterprise Data Security Risks as AI Adoption Expands

Indeterminate GlobeNewswire

Aug. 24, 2026

Biomea Fusion Announces Completion of Enrollment in COVALENT-211 Phase II Trial of Icovamenib in Insulin-Deficient Type 2 Diabetes

Indeterminate GlobeNewswire

Aug. 24, 2026

WRAP: Laser Counter-UAS Technology Added to WrapShield™, Expanding Into DoW, DHS and Tactical Law Enforcement Markets

Indeterminate GlobeNewswire

Aug. 24, 2026

Mesoblast Financial Results and Corporate Update Webcast

Indeterminate GlobeNewswire

Aug. 24, 2026

Tiziana Life Sciences Announces Poster Presentation on Phase 2a BANYAN Clinical Trial of Intranasal Foralumab at ALS Nexus 2026

Indeterminate GlobeNewswire

Aug. 24, 2026

X Square Robot showcases the Power of “One Model, Many Applications” at WRC 2026

Indeterminate GlobeNewswire